We, therefore, propose that the differential regulation of osteoclastogenesis by Notch2/Dll1 and Notch1/Jagged1 axes could be a novel target for the treatment of RA to prevent bone erosion. This evidence concerns the gene DLL1 and rheumatoid arthritis.